144750-42-5,
(S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid hydrochloride,
Clopidogrel impurity A,
(S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno-[3,2-c]pyridin-5(4H)-yl)acetic acid hydrochloride,
Clopidogrel Related Compound A,
FOKSIOUPGDBSLC-UQKRIMTDSA-N,
AK109525,
Clopidogrel carboxylic acid HCl,
SCHEMBL1031048,
KS-00000PE4,
MFCD08063656,
AKOS015950813,
ACN-026583,
DS-4363,
BC228260,
BC644942,
AB1004591,
AX8221119,
ST2402765,
(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride,
Clopidogrel Related Compound A, United States Pharmacopeia (USP) Reference Standard,
Thieno[3,2-c]pyridine-5(4H)-aceticacid,a-(2-chlorophenyl)-6,7-dihydro-,methyl ester,
(2S)-(2-Chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic Acid Hydrochloride (Clopidogrel Acid Hydrochloride),
(2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetic acid;hydrochloride,
(S)-(+)-alpha-(2-chlorophenyl)-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-acetic acid hydrochloride,
(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride,(bisulfate salt equivalent),
(S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridine-5(4H)-yl) acetic acid hydrochloride,
Thieno[3,2-c]pyridine-5(4H)-acetic acid, alpha-(2-chlorophenyl)-6,7-dihydro-, hydrochloride (1:1), (alphaS)-,
clopidogrel carboxylic acid,
Clopidogrel EP Impurity A,
-CLOPIDOGRELHYDROCHLORIDE,
(+/-)-Clopidogrel hydrochloride,
Clopidogrel Carboxylic Acid Hydrochloride,
CS-O-31057,
144457-28-3,
90055-48-4,
(S)-(2-CHLOROPHENYL)-6,7-DIHYDRO-THIENO[3,2-C]PYRIDINE-5(4H)-ACETIC ACID HCL,
(S)-2-(2-Chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)aceticacidhydrochloride,